Median salary
$142,000
per year · annualized USD
Typical range
$101.1k – $171k
25th–75th percentile
Disclosing pay
39.6%
177 of 447 roles
Live roles
447
open right now
Associate Director, Regulatory Affairs (on-site)
Associate Regulatory Affairs Strategy Director (Oncology)
Regulatory Affairs- Senior Manager, Globalization (Registrations)
Regulatory Affairs Senior Manager, Regulatory Information & Content Management
Associate Director, Regulatory Affairs - Biosimilars (US)
Senior Regulatory Affairs Manager – Digital Solutions (on-site)
Associate Director, Regulatory Affairs
Sr Manager Regulatory Affairs- LATAM
| Company | Median | Roles |
|---|---|---|
Abbott
|
$142,000 | 18 |
BD
|
$90,646 | 12 |
Regeneron
|
$142,000 | 11 |
Johnson & Johnson
|
$101,138 | 10 |
| ME Medtronic | $104,000 | 6 |
Gilead Sciences
|
$164,288 | 5 |
Stryker
|
$100,793 | 4 |
Corcept Therapeutics
|
$151,450 | 3 |
| Location | Median | Roles |
|---|---|---|
| Boston | $183,750 | 8 |
| San Francisco | $182,500 | 5 |
| New York | $135,000 | 6 |
| Denver | $97,500 | 3 |
See every Regulatory Affairs role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Regulatory Affairs roles is $142,000 per year. Most pay falls between $101,071 (25th percentile) and $171,000 (75th percentile), with the broader 10th–90th percentile band running from $81,102 to $198,040.
These figures are computed live from 447 active Regulatory Affairs roles on JobsRadar, of which 177 (39.6%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Regulatory Affairs roles include Abbott, Exelixis, BD and Sandoz.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.